This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Sharecare Beheer

Beheer criteriumcontroles 3/4

Sharecare's CEO is Brent Layton, appointed in Jan 2024, has a tenure of less than a year. directly owns 0.62% of the company’s shares, worth €3.03M. The average tenure of the management team and the board of directors is 3.7 years and 3.3 years respectively.

Belangrijke informatie

Brent Layton

Algemeen directeur

US$235.0k

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	less than a year
Eigendom CEO	0.6%
Management gemiddelde ambtstermijn	3.7yrs
Gemiddelde ambtstermijn bestuur	3.3yrs

Recente managementupdates

Recent updates

CEO

Brent Layton (56 yo)

less than a year

Tenure

US$235,000

Compensatie

Mr. Brent Davis Layton serves as Director of Homeward Health Inc. since June 2023. He is Director at Sharecare, Inc. from January 11, 2023 and is its CEO since January 2, 2024. He was Senior Advisor to the...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Jeffrey Arnold	Founder & Executive Chairman	12.8yrs	US$18.19m	2.88% € 14.1m
Brent Layton	CEO & Director	less than a year	US$235.00k	0.62% € 3.0m
Dawn Whaley	President & Chief Marketing Officer	14.8yrs	US$7.28m	0.54% € 2.7m
Justin Ferrero	President & CFO	14.8yrs	US$7.27m	0.52% € 2.5m
Shannon Bagley	Chief Operating Officer	no data	geen gegevens	geen gegevens
Michael Blalock	Chief Accounting Officer & Principal Accounting Officer	2.8yrs	geen gegevens	0.055% € 272.0k
Harsha Panyadahundi	Chief Technology Officer	2.3yrs	geen gegevens	geen gegevens
Walter De Brouwer	Chief Scientific Officer	3.7yrs	geen gegevens	geen gegevens
Colin Daniel	Chief Administrative Officer	2.8yrs	geen gegevens	0.17% € 811.3k
Henry Jay	General Counsel & Diversity Officer	no data	geen gegevens	geen gegevens
Jen Hall	Executive Vice President of Corporate Communications	3.8yrs	geen gegevens	geen gegevens
Dermot Waters	Executive Vice President of Marketing	3.8yrs	geen gegevens	geen gegevens

3.7yrs

Gemiddelde duur

53.5yo

Gemiddelde leeftijd

Ervaren management: 8DJ0's management team is considered experienced (3.7 years average tenure).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Jeffrey Arnold	Founder & Executive Chairman	12.8yrs	US$18.19m	2.88% € 14.1m
Brent Layton	CEO & Director	1.8yrs	US$235.00k	0.62% € 3.0m
Michael Roizen	Member of Advisory Board	no data	geen gegevens	geen gegevens
John Chadwick	Lead Independent Director	3.3yrs	US$290.00k	0.086% € 421.1k
Jeffrey Allred	Independent Director	3.3yrs	US$252.54k	0.19% € 934.0k
Vincent DeVita	Member of Advisory Board	no data	geen gegevens	geen gegevens
Tanya Altmann	Member of Advisory Board	no data	geen gegevens	geen gegevens
Barbara Ficarra	Member of Advisory Board	no data	geen gegevens	geen gegevens
Arthur Crowley	Member of Advisory Board	no data	geen gegevens	geen gegevens
David Demartini	Member of Advisory Board	no data	geen gegevens	geen gegevens
Patricia Geraghty	Member of Advisory Board	no data	geen gegevens	geen gegevens
Sandro Galea	Independent Director	3.3yrs	US$253.23k	0.038% € 185.4k

3.3yrs

Gemiddelde duur

56yo

Gemiddelde leeftijd

Ervaren bestuur: 8DJ0's board of directors are considered experienced (3.3 years average tenure).

This company listing is no longer active

Sharecare Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Chief Administrative Officer recently sold €141k worth of stock

Sharecare, Inc., Annual General Meeting, Jun 13, 2024

Sharecare, Inc Appoints Nicole Torraco to its Board of Directors

Sharecare, Inc. Announces CEO Changes

Sharecare, Inc. Appoints Brent Layton to Its Board of Directors and Audit Committee

Sharecare Names Harsha Panyadahundi Chief Technology Officer

Recent updates

Sharecare, Inc.(NasdaqGM:SHCR) dropped from NASDAQ Composite Index

Altaris, LLC completed the acquisition of Sharecare, Inc. (NasdaqGS:SHCR) from a group of shareholders.

Chief Administrative Officer recently sold €141k worth of stock

New minor risk - Shareholder dilution

Second quarter 2024 earnings released: US$0.12 loss per share (vs US$0.099 loss in 2Q 2023)

Altaris, LLC entered into a definitive agreement to acquire Sharecare, Inc. (NasdaqGS:SHCR) for approximately $520 million.

Sharecare, Inc., Annual General Meeting, Jun 13, 2024

Sharecare, Inc. to Report Q1, 2024 Results on May 09, 2024

Rosen Law Firm Files A Class Action Lawsuit Against Sharecare Inc

Rosen Law Firm Files A Class Action Lawsuit Against Sharecare Inc

Sharecare Receives a Letter from the Listing Qualifications Department of the Nasdaq Stock Market

Sharecare, Inc Appoints Nicole Torraco to its Board of Directors

Sharecare, Inc. announced delayed annual 10-K filing

Sharecare, Inc. to Report Q4, 2023 Results on Mar 13, 2024

Sharecare, Inc. Provides Revenue Guidance for the Fourth Quarter and Fiscal Year Ending December 31, 2023

Third quarter 2023 earnings released: US$0.07 loss per share (vs US$0.078 loss in 3Q 2022)

Sharecare, Inc. Announces CEO Changes

Sharecare, Inc. to Report Q3, 2023 Results on Nov 09, 2023

Second quarter 2023 earnings released: US$0.099 loss per share (vs US$0.084 loss in 2Q 2022)

Sharecare, Inc. Provides Revenue Guidance for the Third Quarter Ending September 30, 2023 and Fiscal Year Ending December 31, 2023

Sharecare Expands Suite of Customer Activation and Management Solutions to Support Patient Education and Improve the Care Journey

Sharecare, Inc. to Report Q2, 2023 Results on Aug 09, 2023

Sharecare, Inc. (NasdaqGS:SHCR) announces an Equity Buyback for $50 million worth of its shares.

Sharecare, Inc. Revises Revenue Guidance for the Fiscal Year Ending December 31, 2023

First quarter 2023 earnings released: US$0.098 loss per share (vs US$0.11 loss in 1Q 2022)

Full year 2022 earnings released: US$0.34 loss per share (vs US$0.30 loss in FY 2021)

Sharecare Launches VR Program to Improve Well-Being of American Workforce and Bring Innovation to Exercise

Sharecare Launches Virtual Model of Its Medicare-Reimbursable Cardiac Rehabilitation Program, Ornish Lifestyle Medicine

Sharecare, Inc. Appoints Brent Layton to Its Board of Directors and Audit Committee

Third quarter 2022 earnings released: US$0.078 loss per share (vs US$0.13 loss in 3Q 2021)

Sharecare, Inc. to Report Q3, 2022 Results on Nov 10, 2022

Sharecare Announces Nine New Digital Solutions Designed to Engage, Educate, and Support People in Managing Their Health

Sharecare Receives Three-Year NCQA Accreditation for Wellness and Health Promotion

Sharecare Launches Self-Service Software Platform to Enable Independent Decentralized Clinical Research

Second quarter 2022 earnings released: US$0.084 loss per share (vs US$8.77 loss in 2Q 2021)

Sharecare, Inc. to Report Q2, 2022 Results on Aug 10, 2022

Sharecare Names Harsha Panyadahundi Chief Technology Officer

No longer forecast to breakeven

First quarter 2022 earnings released: US$0.11 loss per share (vs US$14.23 loss in 1Q 2021)

Sharecare, Inc. (NasdaqGS:SHCR) announces an Equity Buyback for $50 million worth of its shares.

Sharecare Announces Sharecare+, its Whole Health, Payor-Agnostic Advocacy Solution

Forecast breakeven date pushed back to 2023

Sharecare, Inc. to Report Q1, 2022 Results on May 12, 2022

Full year 2021 earnings released: US$0.30 loss per share (vs US$28.48 loss in FY 2020)

Sharecare, Inc. Provides Earning Guidance for the First Quarter Ending March 31, 2022 and Year Ending December 31, 2022

Sharecare, Inc. to Report Q4, 2021 Results on Mar 31, 2022

Forecast to breakeven in 2023

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd